Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
FBCG vs XLV: how they differ
FBCG and XLV hold 4% of their weight in the same names, and XLV returned more over the year.
Fidelity Blue Chip Growth ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, FBCG and XLV hold 4% of their money in the same securities at the same weight.
| Holding | FBCG | XLV |
|---|---|---|
| ELI LILLY and CO | 2.25% | 16.56% |
| GILEAD SCIENCES INC | 0.69% | 2.74% |
| ABBVIE INC | 0.42% | 7.76% |
| JOHNSON and JOHNSON | 0.23% | 10.67% |
| CARDINAL HEALTH INC | 0.20% | 0.97% |
| MCKESSON CORP | 0.19% | 1.59% |
| BOSTON SCIENTIFIC CORP | 0.12% | 1.11% |
| CENCORA INC | 0.12% | 0.96% |
| REGENERON PHARMACEUTICALS INC | 0.09% | 1.09% |
| MODERNA INC | 0.07% | 0.43% |
| UNITEDHEALTH GROUP INC | 0.06% | 6.59% |
| VIATRIS INC | 0.01% | 0.32% |
| Only in FBCG | Only in XLV |
|---|---|
| NVIDIA CORP 14.62% | Merck & Co Inc 5.54% |
| APPLE INC 9.64% | Amgen Inc 3.41% |
| ALPHABET INC 9.10% | Thermo Fisher Scientific Inc 3.25% |
| AMAZON.COM INC 8.43% | Abbott Laboratories 2.76% |
| MICROSOFT CORP 5.20% | Intuitive Surgical Inc 2.46% |
| META PLATFORMS INC 3.90% | Pfizer Inc 2.40% |
| BROADCOM INC 3.74% | CVS Health Corp 2.30% |
| NETFLIX INC 2.23% | Vertex Pharmaceuticals Inc 2.20% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
| FBCG Fidelity Blue Chip Growth ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Fidelity | State Street |
| What it is | Blue Chip Growth | Health care |
| Total return, 1 year | +17.3% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −0.2 pts | +2.9 pts |
| Expense ratio | 0.57% | 0.08% |
| Already in the S&P 500 | 86.8% | 100.0% |
| Holdings | 214 | 59 |
FBCG in plain words
FBCG is an index equity fund tracking the Blue Chip Growth. Over the year to Sep 11, 2026 it returned +17.3% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.57% a year. By its holdings filed for Apr 30, 2026, 87% of the fund by weight is stocks the S&P 500 also holds, across 214 positions, with the top ten at 61.2%. It sat 3.7% below its high of Jun 2, 2026 on Sep 11, 2026.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, FBCG or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, FBCG returned +17.3% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, FBCG or XLV?
- FBCG charges 0.57% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do FBCG and XLV overlap with the S&P 500?
- By their latest filed holdings, 87% of FBCG and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 4% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, FBCG against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/FBCG-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources